Maurizio Pellecchia
University of California, Riverside
H-index: 68
North America-United States
Top articles of Maurizio Pellecchia
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1 | Journal of Medicinal Chemistry | Giulia Alboreggia Parima Udompholkul Carlo Baggio Kendall Muzzarelli Zahra Assar | 2024/5/2 |
Abstract 2460 Structure Studies of Suicide Inhibitors Bound to Human Pin1 | Journal of Biological Chemistry | Gregor Blaha Giulia Alboreggia Isaac Rodriguez Maurizio Pellecchia | 2024/3/1 |
Inhibitors of cancer invasion, attachment, and/or metastasis | 2024/2/6 | ||
Therapeutic compounds and methods | 2021/12/23 | ||
Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1 | Journal of Medicinal Chemistry | Giulia Alboreggia Parima Udompholkul Carlo Baggio Maurizio Pellecchia | 2023/7/19 |
Epha4 targeting compounds and methods of use thereof | 2023/6/29 | ||
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist | Journal of Medicinal Chemistry | Parima Udompholkul Ana Garza-Granados Giulia Alboreggia Carlo Baggio Jack McGuire | 2023/6/1 |
Agents targeting inhibitor of apoptosis proteins | 2023/2/28 | ||
EPHA2 agonists and uses thereof | 2023/8/29 | ||
EphA4 targeting agents protect motor neurons from cell death induced by amyotrophic lateral sclerosis-astrocytes | Iscience | Cassandra Dennys Carlo Baggio Rochelle Rodrigo Florence Roussel Anna Kulinich | 2022/9/16 |
Targefrin: a potent agent targeting the ligand binding domain of EphA2 | Journal of Medicinal Chemistry | Carlo Baggio Parima Udompholkul Luca Gambini Maurizio Pellecchia | 2022/11/4 |
Lysine covalent antagonists of melanoma inhibitors of apoptosis protein | Journal of Medicinal Chemistry | Parima Udompholkul Carlo Baggio Luca Gambini Giulia Alboreggia Maurizio Pellecchia | 2021/10/27 |
NMR-guided design of potent and selective EphA4 agonistic ligands | Journal of medicinal chemistry | Carlo Baggio Anna Kulinich Cassandra N Dennys Rochelle Rodrigo Kathrin Meyer | 2021/7/22 |
Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates | Molecules | Parima Udompholkul Carlo Baggio Luca Gambini Yu Sun Ming Zhao | 2021/6/17 |
Design, synthesis, and structural characterization of lysine covalent BH3 peptides targeting Mcl-1 | Journal of medicinal chemistry | Luca Gambini Parima Udompholkul Carlo Baggio Aruljothi Muralidharan Nikola Kenjić | 2021/4/2 |
Potential therapeutic targeting of coronavirus spike glycoprotein priming | Molecules | Elisa Barile Carlo Baggio Luca Gambini Sergey A Shiryaev Alex Y Strongin | 2020/5/22 |
Stability and cell permeability of sulfonyl fluorides in the design of Lys‐covalent antagonists of protein‐protein interactions | ChemMedChem | Luca Gambini Parima Udompholkul Ahmed F Salem Carlo Baggio Maurizio Pellecchia | 2020/11/18 |
Therapeutic targeting of pancreatic cancer via EphA2 dimeric agonistic agents | Pharmaceuticals | Ahmed F Salem Luca Gambini Parima Udompholkul Carlo Baggio Maurizio Pellecchia | 2020/5/10 |
Therapeutic targeting of MMP-12 for the treatment of chronic obstructive pulmonary disease | Journal of medicinal chemistry | Carlo Baggio Jalene V Velazquez Marco Fragai Tara M Nordgren Maurizio Pellecchia | 2020/10/27 |
Therapeutic targeting of coronavirus spike glycoprotein priming | Elisa Barile Carlo Baggio Luca Gambini Sergey A Shiryaev Alex Y Strongin | 2020/4/9 |